NRX Pharmaceuticals, Inc. (NRXP)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
Apr 02, 16:00
2.26
+0.06
(+2.73%)
Pre-Market: 08:35
NRX Pharmaceuticals Total Assets (Quarterly) : 12.96M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Synergy CHC Corp. | 10.16M |
| Vivos Therapeutics, Inc. | 25.64M |
| Lantern Pharma, Inc. | 11.04M |
| IGC Pharma, Inc. | 9.712M |
| Vertex Pharmaceuticals, Inc. | 26.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.89M |
| Shareholders Equity (Quarterly) | -15.94M |
| Debt to Equity Ratio | -0.0396 |
| Current Ratio | 0.3111 |
| Net Debt Paydown Yield | 1.40% |